These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 189384)

  • 21. Studies of sympatho-adrenal reactivity and adrenoceptor function in bronchial asthma.
    Larsson K
    Eur J Respir Dis Suppl; 1985; 141():1-52. PubMed ID: 3858102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of inhaled RS 7540, a xanthone, on exercise-induced asthma.
    Stenius B; Salorinne Y; Parrott D
    Scand J Respir Dis; 1978 Apr; 59(2):75-81. PubMed ID: 356252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine].
    Pradalier A; Dry J; Loisy B; Meininger V; Vicaut E; Mirabaud C; Levy M
    Therapie; 1988; 43(4):293-7. PubMed ID: 3055407
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of beta-adrenoreceptor stimulants on exercise-induced asthma.
    Sly RM
    Pediatrics; 1975 Nov; 56(5 pt-2 suppl):910-5. PubMed ID: 241968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
    Leier CV; Binkley PF; Randolph PH; Unverferth DV
    J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical cardiac electrophysiological assessment of indoramin.
    Butrous GS; Camm AJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical pharmacology of indoramin.
    Shanks RG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S8-15. PubMed ID: 2423804
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
    Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
    Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of indoramin on exercise performance in mild hypertension.
    Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Indoramin in prevention of migraine.
    Wainscott G; Volans GN; Wilkinson M; Faux GA
    Lancet; 1975 Jul; 2(7923):32-3. PubMed ID: 49624
    [No Abstract]   [Full Text] [Related]  

  • 33. Alpha-adrenergic blocking agents in the treatment of asthma.
    Smith SR
    J Clin Hosp Pharm; 1983 Jun; 8(2):201-8. PubMed ID: 6135718
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: practolol, indoramin, and asthma.
    Paice E; El Hassan ES
    Br Med J; 1975 Jun; 2(5971):617. PubMed ID: 1131650
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible use of indoramin in patients with chronic neurogenic bladder dysfunction.
    Vaidyanathan S; Rao MS; Sharma PL; Chary KS; Swamy RP
    J Urol; 1983 Jan; 129(1):96-101. PubMed ID: 6827693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial of an alpha-adrenolytic drug (indoramin) for nocturnal enuresis.
    Shaffer D; Hedge B; Stephenson J
    Dev Med Child Neurol; 1978 Apr; 20(2):183-8. PubMed ID: 25217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre controlled trial of indoramin in the symptomatic relief of benign prostatic hypertrophy.
    Chow W; Hahn D; Sandhu D; Slaney P; Henshaw R; Das G; Wells P
    Br J Urol; 1990 Jan; 65(1):36-8. PubMed ID: 1690068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoramin in the hypertensive patient with concomitant disease: clinical experience.
    Rosendorff C
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S93-7. PubMed ID: 2423808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind trial of indoramin in digital artery disease.
    Robson P; Pearce V; Antcliff AC; Hamilton M
    Br J Clin Pharmacol; 1978 Jul; 6(1):88-91. PubMed ID: 352379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.